Skip to content
2000
image of Cardiovascular Disorders in Systemic Lupus Erythematosus

Abstract

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease with multiorgan and system involvement, including the Cardiovascular (CV) system. Cardiac involvement in these patients is frequent and most often asymptomatic, at least in the early stages. It includes accelerated atherosclerosis, premature Coronary Artery Disease (CAD), and a high risk of CV complications. The risk of developing CV Disease (CVD) in SLE is linked not only with classical CV risk factors but also with disease-specific factors, like the degree of activity, autoantibodies, organ damage, and type of therapy. Clinical presentation comprises several clinical manifestations ranging from angina to acute Myocardial Infarction (MI) and Sudden Cardiac Death (SCD). The leading cause of death in SLE patients is from CVD due to accelerated atherosclerosis, which often has a more rapid progression compared with the general population. The CV risk in SLE is greater when antiphospholipid antibodies are present. Regarding diagnosis, apart from relevant blood tests, the simplest and readily available diagnostic test, echocardiography, with its contemporary techniques that include global longitudinal strain, is needed to provide a more thorough cardiac evaluation and allow for early management. These aspects of the disease, together with issues regarding phenotypes, biomarkers, neonatal lupus, heart block, SLE-related CV ailments such as coronary artery disease (CAD), myocarditis, valvular heart disease, and the antiphospholipid syndrome, as well as diagnostic modalities, drug and interventional therapies, and current relevant guidelines are all thoroughly reviewed and discussed in this article.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cvp/10.2174/0115701611348352250319034731
2025-04-08
2025-09-26

  • From This Site

    /content/journals/cvp/10.2174/0115701611348352250319034731
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. McMahon M. Hahn B.H. Skaggs B.J. Systemic lupus erythematosus and cardiovascular disease: Prediction and potential for therapeutic intervention. Expert Rev. Clin. Immunol. 2011 7 2 227 241 10.1586/eci.10.98 21426260
    [Google Scholar]
  2. Nor M.A. Ogedegbe O.J. Barbarawi A. Ali A.I. Sheikh I.M. Yussuf F.M. Adam S.M. Hassan O.A. Tabowei G. Jimoh A. Mejulu E.O. Cheema A.Y. Systemic lupus erythematosus and cardiovascular diseases: A systematic review. Cureus 2023 15 5 e39284 10.7759/cureus.39284 37346216
    [Google Scholar]
  3. Alammari Y. Albednah F.A. Alharbi K.A. Alrashoudi A.M. Alsharif A.Y. Alkahtani A.H. Alshehry H.Z. Alajaji A.A. Alsaedi A.M. Al harbi K. Qutob R.A. Almansour M. Cardiovascular morbidity in systemic lupus erythematosus: A single-center retrospective study. Cureus 2024 16 4 e57842 10.7759/cureus.57842 38721162
    [Google Scholar]
  4. Chourabi S. Sayhi S. Ben Ameur S. Chourabi C. Mahfoudhi H. Fehri W. Ben Abdelhafidh N. Cardiac involvement in systemic lupus erythematosus: Interest of 2D global longitudinal strain. Lupus 2024 33 10 1100 1108 10.1177/09612033241266990 39041544
    [Google Scholar]
  5. Chen J. Tang Y. Zhu M. Xu A. Heart involvement in systemic lupus erythematosus: A systemic review and meta-analysis. Clin. Rheumatol. 2016 35 10 2437 2448 10.1007/s10067‑016‑3373‑z 27502777
    [Google Scholar]
  6. Andrades C. Fuego C. Manrique-Arija S. Fernández-Nebro A. Management of cardiovascular risk in systemic lupus erythematosus: A systematic review. Lupus 2017 26 13 1407 1419 10.1177/0961203317704710 28457197
    [Google Scholar]
  7. Tselios K. Sheane B.J. Gladman D.D. Urowitz M.B. Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: A systematic review. J. Rheumatol. 2016 43 1 54 65 10.3899/jrheum.150460 26568591
    [Google Scholar]
  8. Melano-Carranza E. Zambrano-Zambrano A. Valle-Uitzil W. Ezquerra-Osorio A. Rodriguez-Méndez A. Larios-Lara J.H. Baeza L. Pimentel-Esparza J.A. Cervantes-Nieto J.A. Fuentes Mendoza J.A. Coronary artery disease in systemic lupus erythematosus: What do the facts say? Cureus 2023 15 1 e33449 10.7759/cureus.33449 36751191
    [Google Scholar]
  9. Bundhun P.K. Boodhoo K.D. Long M.Y. Chen M.H. Impact of antiphospholipid syndrome and/or systemic lupus erythematosus on the long-term adverse cardiovascular outcomes in patients after percutaneous coronary intervention. Medicine (Baltimore) 2016 95 12 e3200 10.1097/MD.0000000000003200 27015221
    [Google Scholar]
  10. Lee Y.H. Song G.G. Mortality in patients with systemic lupus erythematosus: A meta-analysis of overall and cause-specific effects. Lupus 2024 33 9 929 937 10.1177/09612033241257134 38769901
    [Google Scholar]
  11. Lu X. Wang Y. Zhang J. Pu D. Hu N. Luo J. An Q. He L. Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: A systematic review and Meta-analysis. Int. Immunopharmacol. 2021 94 107466 10.1016/j.intimp.2021.107466 33636561
    [Google Scholar]
  12. Tobin R. Patel N. Tobb K. Weber B. Mehta P.K. Isiadinso I. Atherosclerosis in systemic lupus erythematosus. Curr. Atheroscler. Rep. 2023 25 11 819 827 10.1007/s11883‑023‑01149‑4 37768411
    [Google Scholar]
  13. Ballocca F. D’Ascenzo F. Moretti C. Omedè P. Cerrato E. Barbero U. Abbate A. Bertero M.T. Zoccai G.B. Gaita F. Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2015 22 11 1435 1441 10.1177/2047487314546826 25139772
    [Google Scholar]
  14. Bartels C.M. Buhr K.A. Goldberg J.W. Bell C.L. Visekruna M. Nekkanti S. Greenlee R.T. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J. Rheumatol. 2014 41 4 680 687 10.3899/jrheum.130874 24532834
    [Google Scholar]
  15. Zen M. Salmaso L. Barbiellini Amidei C. Fedeli U. Bellio S. Iaccarino L. Doria A. Saia M. Mortality and causes of death in systemic lupus erythematosus over the last decade: Data from a large population-based study. Eur. J. Intern. Med. 2023 112 45 51 10.1016/j.ejim.2023.02.004 36774306
    [Google Scholar]
  16. Fanlo-Maresma M. Candás-Estébanez B. Esteve-Luque V. Padró-Miquel A. Escrihuela-Vidal F. Carratini-Moraes M. Corbella E. Corbella X. Pintó X. Asymptomatic carotid atherosclerosis cardiovascular risk factors and common hypertriglyceridemia genetic variants in patients with systemic erythematosus lupus. J. Clin. Med. 2021 10 10 2218 10.3390/jcm10102218 34065555
    [Google Scholar]
  17. Rodríguez R.D. Alarcón-Riquelme M.E. Exploring the contribution of genetics on the clinical manifestations of systemic lupus erythematosus. Best Pract. Res. Clin. Rheumatol. 2024 ••• 101971 10.1016/j.berh.2024.101971 39013664
    [Google Scholar]
  18. Liu Y. Yu X. Zhang W. Zhang X. Wang M. Ji F. Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus. J. Autoimmun. 2022 132 102863 10.1016/j.jaut.2022.102863 35853760
    [Google Scholar]
  19. Leonard D. Svenungsson E. Dahlqvist J. Alexsson A. Ärlestig L. Taylor K.E. Sandling J.K. Bengtsson C. Frodlund M. Jönsen A. Eketjäll S. Jensen-Urstad K. Gunnarsson I. Sjöwall C. Bengtsson A.A. Eloranta M.L. Syvänen A.C. Rantapää-Dahlqvist S. Criswell L.A. Rönnblom L. Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis. Ann. Rheum. Dis. 2018 77 7 1063 1069 10.1136/annrheumdis‑2017‑212614 29514802
    [Google Scholar]
  20. Schanberg L.E. Sandborg C. Barnhart H.X. Ardoin S.P. Yow E. Evans G.W. Mieszkalski K.L. Ilowite N.T. Eberhard A. Levy D.M. Kimura Y. von Scheven E. Silverman E. Bowyer S.L. Punaro L. Singer N.G. Sherry D.D. McCurdy D. Klein-Gitelman M. Wallace C. Silver R. Wagner-Weiner L. Higgins G.C. Brunner H.I. Jung L. Soep J.B. Reed A. Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima‐media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort. Arthritis Rheum. 2009 60 5 1496 1507 10.1002/art.24469 19404953
    [Google Scholar]
  21. Bolla E. Semb A.G. Kerola A.M. Ikdahl E. Petri M. Pons-Estel G.J. Karpouzas G.A. Sfikakis P.P. Quintana R. Misra D.P. Borba E.F. Garcia-de la Torre I. Popkova T.V. Artim-Esen B. Troldborg A. Fragoso-Loyo H. Ajeganova S. Yazici A. Aroca-Martinez G. Direskeneli H. Ugarte-Gil M.F. Mosca M. Goyal M. Svenungsson E. Macieira C. Hoi A. Lerang K. Costedoat-Chalumeau N. Tincani A. Mirrakhimov E. Acosta Colman I. Danza A. Massardo L. Blagojevic J. Yılmaz N. Tegzová D. Yavuz S. Korkmaz C. Hachulla E. Moreno Alvarez M.J. Muñoz-Louis R. Pantazis N. Tektonidou M.G. Bellomio V. Cavazzana I. Khmelinskii N. Monticielo O.A. Portela Hernández M. Saavedra Salinas M.A. Scolnik M. Silva Montandon A.C. Yilmaz E. Zucchi D. SURF-SLE and APS collaborators Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: A cross-sectional study including 3401 individuals from 24 countries. Lancet Rheumatol. 2024 6 7 e447 e459 10.1016/S2665‑9913(24)00090‑0 38878780
    [Google Scholar]
  22. Smaira F.I. Mazzolani B.C. Sieczkowska S.M. Romero M. Ribeiro T.T. Amarante M.C. Pasoto S. Pinto A.L.S. Lima F.R. Benatti F.B. Roschel H. Gualano B. Food consumption, physical activity and aerobic capacity in systemic lupus erythematosus patients with high cardiovascular risk. Clinics 2024 79 100418 10.1016/j.clinsp.2024.100418 39003927
    [Google Scholar]
  23. Butt S. Kiran S. Qadir N. Menghani D. Tanzeem H. Cardiac conduction defects in systemic lupus erythematosus. Cureus 2020 12 10 e10882 10.7759/cureus.10882 33178534
    [Google Scholar]
  24. Yazdany J. Pooley N. Langham J. Nicholson L. Langham S. Embleton N. Wang X. Desta B. Barut V. Hammond E. Systemic lupus erythematosus; Stroke and myocardial infarction risk: A systematic review and meta-analysis. RMD Open 2020 6 2 e001247 10.1136/rmdopen‑2020‑001247 32900883
    [Google Scholar]
  25. Bello N. Meyers K.J. Workman J. Hartley L. McMahon M. Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis. Lupus 2023 32 3 325 341 10.1177/09612033221147471 36547368
    [Google Scholar]
  26. Semalulu T. Tago A. Zhao K. Tselios K. Managing cardiovascular risk in systemic lupus erythematosus: Considerations for the clinician. ImmunoTargets Ther. 2023 12 175 186 10.2147/ITT.S377076 38089168
    [Google Scholar]
  27. Manolis A.S. Tzioufas A.G. Cardio-rheumatology: Cardiovascular complications in systemic autoimmune rheumatic diseases / is inflammation the common link and target? Curr. Vasc. Pharmacol. 2020 18 5 425 430 10.2174/1570161118666200514222236 32410564
    [Google Scholar]
  28. Zeller C. Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: The role of traditional and lupus related risk factors. Curr. Cardiol. Rev. 2008 4 2 116 122 10.2174/157340308784245775 19936286
    [Google Scholar]
  29. Polytarchou K. Varvarousis D. Manolis A.S. Cardiovascular disease in antiphospholipid syndrome. Curr. Vasc. Pharmacol. 2020 18 6 538 548 10.2174/1570161117666190830101341 31530257
    [Google Scholar]
  30. Bourg C. Le Tallec E. Curtis E. Lee C. Bouzille G. Oger E. Lescort A. Donal E. Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort. Open Heart 2024 11 1 e002615 10.1136/openhrt‑2024‑002615 38702088
    [Google Scholar]
  31. Al-Zahir M.Z. Chan K.L. Echocardiography in systemic lupus erythematosus. Curr. Cardiol. Rep. 2024 26 11 1265 1271 10.1007/s11886‑024‑02121‑7 39186230
    [Google Scholar]
  32. Liu Y. Yin S. Lin Z. Zhao C. Zhang H. Two-dimensional speckle-tracking echocardiography in left ventricular systolic function in patients with systemic lupus erythematosus. Clin. Rheumatol. 2024 43 6 1871 1880 10.1007/s10067‑024‑06929‑0 38653848
    [Google Scholar]
  33. Akiash N. Abbaspour S. Mowla K. Moradi A. Madjidi S. Sharifi P. Pazoki M. Three-dimensional speckle tracking echocardiography for evaluation of ventricular function in patients with systemic lupus erythematosus: Relationship between duration of lupus erythematosus and left ventricular dysfunction by using global longitudinal strain. Egypt. Heart J. 2024 76 1 79 10.1186/s43044‑024‑00511‑4 38914877
    [Google Scholar]
  34. Hagiwara A.M. Montano E. Tumurkhuu G. Bose M. Bernardo M. Berman D.S. Wiens G.C. Nelson M.D. Wallace D.J. Wei J. Ishimori M. Bairey Merz C.N. Jefferies C. Reduced left ventricular function on cardiac MRI in SLE patients correlates with measures of SLE disease activity and inflammation. J Radiol Clin Imaging 2023 6 4 197 207 10.26502/jrci.2809088 38505536
    [Google Scholar]
  35. Mercader-Salvans J. García-González M. Quevedo-Abeledo J.C. Quevedo-Rodríguez A. Gómez-Bernal F. Hernández-Díaz M. Pestana-Eliche M. Markthaler M. Martín-González C. Gómez-Moreno C. González-Gay M.Á. Ferraz-Amaro I. Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 2024 42 9 1773 1780 38757296
    [Google Scholar]
  36. Bagare P.C. Borle A. Baluni P. Ekbote G.G. Sangale S. Clinical profile and outcomes of patients with systemic lupus erythematosus. Cureus 2024 16 9 e68541 10.7759/cureus.68541 39364459
    [Google Scholar]
  37. Manolis A.S. Manolis T.A. Melita H. Atherosclerosis: An athero-thrombo-inflammatory disease. Hosp. Chron. 2012 7 195 201
    [Google Scholar]
  38. Korkmaz C. Cansu D.U. Kaşifoğlu T. Myocardial infarction in young patients (≤35 years of age) with systemic lupus erythematosus: A case report and clinical analysis of the literature. Lupus 2007 16 4 289 297 10.1177/0961203307078001 17439937
    [Google Scholar]
  39. Vavlukis M. Pop-Gjorcevab D. Poposka L. Sandevska E. Kedev S. Myocardial infarction in systemic lupus erythematosus – The sex-specific risk profile. Curr. Pharm. Des. 2021 27 29 3221 3228 10.2174/1381612826666201210110809 33302858
    [Google Scholar]
  40. Sagheer S. Deka P. Pathak D. Khan U. Zaidi S.H. Akhlaq A. Blankenship J. Annis A. Clinical outcomes of acute myocardial infarction hospitalizations with systemic lupus erythematosus: An analysis of nationwide readmissions database. Curr. Probl. Cardiol. 2022 47 11 101086 10.1016/j.cpcardiol.2021.101086 34936910
    [Google Scholar]
  41. Samuelsson I. Parodis I. Gunnarsson I. Zickert A. Hofman-Bang C. Wallén H. Svenungsson E. Myocardial infarctions, subtypes and coronary atherosclerosis in SLE: A case–control study. Lupus Sci. Med. 2021 8 1 e000515 10.1136/lupus‑2021‑000515 34290127
    [Google Scholar]
  42. Mattu A. Petrini J. Swencki S. Chaudhari C. Brady W.J. Premature atherosclerosis and acute coronary syndrome in systemic lupus erythematosus. Am. J. Emerg. Med. 2005 23 5 696 703 10.1016/j.ajem.2004.12.012 16140181
    [Google Scholar]
  43. Whittier M. Bautista Sanchez R. Arora S. Manadan A.M. Systemic lupus erythematosus and antiphospholipid antibody syndrome as risk factors for acute coronary syndrome in young patients. J. Clin. Rheumatol. 2022 28 3 143 146 10.1097/RHU.0000000000001824 35293887
    [Google Scholar]
  44. Manolis A.S. Manolis A.A. Manolis T.A. Melita H. Acute coronary syndromes in patients with angiographically normal or near normal (non-obstructive) coronary arteries. Trends Cardiovasc. Med. 2018 28 8 541 551 10.1016/j.tcm.2018.05.006 29859655
    [Google Scholar]
  45. Álvarez-Lario B. Álvarez-Roy L. Mayordomo-Gómez S. García-García J.M. Spontaneous coronary artery dissection in systemic lupus erythematosus: Case-based review. Rheumatol. Int. 2019 39 10 1821 1827 10.1007/s00296‑019‑04351‑3 31227856
    [Google Scholar]
  46. Mandell B.F. Cardiovascular involvement in systemic lupus erythematosus. Semin. Arthritis Rheum. 1987 17 2 126 141 10.1016/0049‑0172(87)90035‑7 3334284
    [Google Scholar]
  47. Dein E. Douglas H. Petri M. Law G. Timlin H. Pericarditis in Lupus. Cureus 2019 11 3 e4166 31086751
    [Google Scholar]
  48. Kao A.H. Lertratanakul A. Elliott J.R. Sattar A. Santelices L. Shaw P. Birru M. Avram Z. Thompson T. Sutton-Tyrrell K. Ramsey-Goldman R. Manzi S. Relation of carotid intima-media thickness and plaque with incident cardiovascular events in women with systemic lupus erythematosus. Am. J. Cardiol. 2013 112 7 1025 1032 10.1016/j.amjcard.2013.05.040 23827400
    [Google Scholar]
  49. Nossent J.C. Keen H.I. Preen D.B. Inderjeeth C.A. Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus. Lupus 2024 33 8 787 796 10.1177/09612033241247359 38655753
    [Google Scholar]
  50. Bernardi M. Spadafora L. Andaloro S. Piscitelli A. Fornaci G. Intonti C. Fratta A.E. Hsu C.E. Kaziròd-Wolski K. Metsovitis T. Biondi-Zoccai G. Sabouret P. Marzetti E. Cacciatore S. Management of cardiovascular complications in antiphospholipid syndrome: A narrative review with a focus on older adults. J. Clin. Med. 2024 13 11 3064 10.3390/jcm13113064 38892776
    [Google Scholar]
  51. Gómez-Puerta J.A. Cervera R. Diagnosis and classification of the antiphospholipid syndrome. J. Autoimmun. 2014 48-49 20 25 10.1016/j.jaut.2014.01.006 24461539
    [Google Scholar]
  52. Andreoli L. Chighizola C.B. Banzato A. Pons-Estel G.J. de Jesus G.R. Erkan D. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature. Arthritis Care Res. 2013 65 11 1869 1873 10.1002/acr.22066 23861221
    [Google Scholar]
  53. Luo L. Cai Q. Liu X. Yun Z. Li X. Yan R. Li C. Characteristics and prognosis of elderly-onset antiphospholipid syndrome: An observational cohort study. Lupus 2024 33 10 1034 1042 10.1177/09612033241266875 39033374
    [Google Scholar]
  54. Pons-Estel G.J. Andreoli L. Scanzi F. Cervera R. Tincani A. The antiphospholipid syndrome in patients with systemic lupus erythematosus. J. Autoimmun. 2017 76 10 20 10.1016/j.jaut.2016.10.004 27776934
    [Google Scholar]
  55. Nagy N. Bói B. Papp G. Fiák E. Gáspár-Kiss E. Perge B. Farmasi N. Tarr T. Antiphospholipid antibodies are major risk factors for non-thrombotic cardiac complications in systemic lupus erythematosus. Biomedicines 2024 12 3 530 10.3390/biomedicines12030530 38540143
    [Google Scholar]
  56. Chen S. Zhou Y. Wang C. Jiang H. Zhao Y. Zhao J. Huang C. Li M. Zhao Y. Impact of antiphospholipid antibodies on cardiac valve lesions in systemic lupus erythematosus: A systematic review and meta-analysis. Clin. Exp. Med. 2024 24 1 147 10.1007/s10238‑024‑01406‑z 38960899
    [Google Scholar]
  57. Siniscalchi C. Basaglia M. Riva M. Meschi M. Meschi T. Castaldo G. Di Micco P. Catastrophic antiphospholipid syndrome: A review. Immuno 2023 4 1 1 13 10.3390/immuno4010001
    [Google Scholar]
  58. Jacobs L. Wauters N. Lablad Y. Morelle J. Taghavi M. Diagnosis and management of catastrophic antiphospholipid syndrome and the potential impact of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Antibodies 2024 13 1 21 10.3390/antib13010021 38534211
    [Google Scholar]
  59. Bitsadze V. Yakubova F. Khizroeva J. Lazarchuk A. Salnikova P. Vorobev A. Tretyakova M. Degtyareva N. Grigoreva K. Gashimova N. Kvaratskheliia M. Makatsariya N. Kudryavtseva E. Tomlenova A. Gris J.C. Elalamy I. Ay C. Makatsariya A. Catastrophic antiphospholipid syndrome. Int. J. Mol. Sci. 2024 25 1 668 10.3390/ijms25010668 38203837
    [Google Scholar]
  60. Pons I. Jeréz A. Espinosa G. Rodríguez-Pintó I. Erkan D. Shoenfeld Y. Cervera R. CAPS Registry Project Group/European Forum on Antiphospholipid Antibodies (supplementary material 1) Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the “CAPS registry”. Semin. Arthritis Rheum. 2024 66 152439 10.1016/j.semarthrit.2024.152439 38552300
    [Google Scholar]
  61. Liu Y. Kaplan M.J. Cardiovascular disease in systemic lupus erythematosus: An update. Curr. Opin. Rheumatol. 2018 30 5 441 448 10.1097/BOR.0000000000000528 29870498
    [Google Scholar]
  62. Wong C.Y. Ma B.M.Y. Zhang D. Cheung W. Chan T.M. Yap D.Y.H. Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: A systematic review and meta-analysis. Lupus Sci. Med. 2024 11 1 e001152 10.1136/lupus‑2024‑001152 38519060
    [Google Scholar]
  63. Dhakal B.P. Kim C.H. Al-Kindi S.G. Oliveira G.H. Heart failure in systemic lupus erythematosus. Trends Cardiovasc. Med. 2018 28 3 187 197 10.1016/j.tcm.2017.08.015 28927572
    [Google Scholar]
  64. Wagner B.R. Rao P.S. Sodium-glucose cotransporter 2 inhibitors: Are they ready for prime time in the management of lupus nephritis? Curr. Opin. Rheumatol. 2024 36 3 163 168 10.1097/BOR.0000000000001002 38517337
    [Google Scholar]
  65. Derdulska J.M. Rudnicka L. Szykut-Badaczewska A. Mehrholz D. Nowicki R.J. Barańska-Rybak W. Wilkowska A. Neonatal lupus erythematosus – Practical guidelines. J. Perinat. Med. 2021 49 5 529 538 10.1515/jpm‑2020‑0543 33470961
    [Google Scholar]
  66. Manolis A.A. Manolis T.A. Melita H. Manolis A.S. Congenital heart block: Pace earlier (Childhood) than later (Adulthood). Trends Cardiovasc. Med. 2020 30 5 275 286 10.1016/j.tcm.2019.06.006 31262557
    [Google Scholar]
  67. Dalal D.S. Patel K.A. Patel M.A. Systemic lupus erythematosus and pregnancy: A brief review. J. Obstet. Gynaecol. India 2019 69 2 104 109 10.1007/s13224‑019‑01212‑8 30956462
    [Google Scholar]
  68. Lu J. Xu D. Wan Q. Chen H. Pregnancy outcomes and risk factors analysis in patients with systemic lupus erythematous. BMC Pregnancy Childbirth 2024 24 1 495 10.1186/s12884‑024‑06701‑x 39039448
    [Google Scholar]
  69. Romero J. Elkattawy S. Abboud R. Masood A. Jawed Q. Romero A.L. Fichadiya H.A. Abu-Samak A.A. Shamoon Y.F. Elkattawy O. Joshi M. Shamoon F.E. Severe mitral valve regurgitation secondary to fulminant myocarditis in the setting of a lupus flare. J. Community Hosp. Intern. Med. Perspect. 2024 14 3 81 84 10.55729/2000‑9666.1336 39036581
    [Google Scholar]
  70. Guglin M. Smith C. Rao R. The spectrum of lupus myocarditis: From asymptomatic forms to cardiogenic shock. Heart Fail. Rev. 2021 26 3 553 560 10.1007/s10741‑020‑10054‑w 33210224
    [Google Scholar]
  71. Ramirez GA Holopainen NEA Gerosa M Distinctive clinical traits of lupus-related myocarditis: A multicentre retrospective study. Rheumatology 2024 10.1093/rheumatology/keae376
    [Google Scholar]
  72. Kosałka-Węgiel J. Pacholczak-Madej R. Dziedzic R. Siwiec-Koźlik A. Spałkowska M. Milewski M. Zaręba L. Bazan-Socha S. Korkosz M. Malignancy in systemic lupus erythematosus: Relation to disease characteristics in 92 patients – A single center retrospective study. Rheumatol. Int. 2024 44 9 1701 1713 10.1007/s00296‑024‑05623‑3
    [Google Scholar]
  73. Oliveira C. Temesgen-Oyelakin Y. Naqi M. Davis M. Naz F. Dell’Orso S. Brooks S. Kuhn S. Hill T. Li X. Patel N. Parel P. Gadina M. Gupta S. Mehta N. Hasni S.A. Kaplan M.J. A multiomic analysis to identify drivers of subclinical vascular disease in systemic lupus erythematosus. Arthritis Rheumatol. 2024 76 10 art.42925 10.1002/art.42925 38923259
    [Google Scholar]
  74. Shao K. Yuan F. Chen F. Wang J. Shao X. Zhang F. Zhu B. Wang Y. Assessing myocardial involvement in systemic lupus erythematosus patients without cardiovascular symptoms by technetium-99m-sestamibi myocardial perfusion imaging: A correlation study on NT-proBNP. Curr. Med. Imaging Rev. 2023 19 10 e231122211148 10.2174/1573405619666221123103546 36420877
    [Google Scholar]
  75. Khayata M. Wang T.K.M. Chan N. Alkharabsheh S. Verma B.R. Oliveira G.H. Klein A.L. Littlejohn E. Xu B. Multimodality cardiac imaging in patients with systemic lupus erythematosus. Curr. Probl. Cardiol. 2023 48 3 101048 10.1016/j.cpcardiol.2021.101048 34774920
    [Google Scholar]
  76. Lai L. Wang L. Li S. Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus. Lupus 2024 33 10 1059 1068 10.1177/09612033241266083 39052974
    [Google Scholar]
  77. Azpiri-Lopez J.R. Galarza-Delgado D.A. Garza-Cisneros A.N. Guajardo-Jauregui N. Balderas-Palacios M.A. Garcia-Heredia A. Cardenas-de la Garza J.A. Rodriguez-Romero A.B. Reyna-de la Garza R.A. Azpiri-Diaz H. Alonso-Cepeda O. Colunga-Pedraza I.J. Subclinical systolic dysfunction by speckle tracking echocardiography in patients with systemic lupus erythematosus. Lupus 2022 31 9 1127 1131 10.1177/09612033221106581 35642711
    [Google Scholar]
  78. Markousis-Mavrogenis G. Pepe A. Lupi A. Apostolou D. Argyriou P. Velitsista S. Vartela V. Quaia E. Mavrogeni S.I. Combined brain-heart MRI identifies cardiac and white matter lesions in patients with systemic lupus erythematosus and/or antiphospholipid syndrome: A pilot study. Eur. J. Radiol. 2024 176 111500 10.1016/j.ejrad.2024.111500 38772161
    [Google Scholar]
  79. du Toit R. Karamchand S. Doubell A.F. Reuter H. Herbst P.G. Lupus myocarditis: Review of current diagnostic modalities and their application in clinical practice. Rheumatology 2023 62 2 523 534 10.1093/rheumatology/keac409 35861382
    [Google Scholar]
  80. Gartshteyn Y. Tamargo M. Fleischer S. Kapoor T. Li J. Askanase A. Winchester R. Geraldino-Pardilla L. Endomyocardial biopsies in the diagnosis of myocardial involvement in systemic lupus erythematosus. Lupus 2020 29 2 199 204 10.1177/0961203319897116 31924147
    [Google Scholar]
  81. Rúa-Figueroa Í. Salman-Monte T.C. Pego Reigosa J.M. Galindo Izquierdo M. Díez Álvarez E. Fernández-Nebro A. Román Ivorra J.A. Calvo Penades I. Artaraz Beobide J. Calvo Alén J. Multidisciplinary consensus on the use of hydroxychloroquine in patients with systemic lupus erythematosus. Reumatología Clínica 2024 20 6 312 319 10.1016/j.reumae.2024.03.002 38991825
    [Google Scholar]
  82. Maksimowicz-McKinnon K. Selzer F. Manzi S. Kip K.E. Mulukutla S.R. Marroquin O.C. Smitherman T.C. Kuller L.H. Williams D.O. Wasko M.C.M. Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: Report from the national heart, lung, and blood institute dynamic registry. Circ. Cardiovasc. Interv. 2008 1 3 201 208 10.1161/CIRCINTERVENTIONS.108.788745 20031679
    [Google Scholar]
/content/journals/cvp/10.2174/0115701611348352250319034731
Loading
Cardiovascular Disorders in Systemic Lupus Erythematosus
Bentham Science Publishers ; https://doi.org/10.2174/0115701611348352250319034731
/content/journals/cvp/10.2174/0115701611348352250319034731
/content/journals/cvp/10.2174/0115701611348352250319034731
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: coronary artery disease ; neonatal lupus ; sudden death ; valvular heart disease ; antiphospholipid antibodies ; autoantibodies ; multimodality cardiac imaging ; coronary revascularization ; heart block ; autoimmune disease ; thromboembolism ; cardiovascular disease ; echocardiography ; myocardial infarction ; Systemic lupus erythematosus ; myocarditis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test